ARaymondlife continues to develop and commercialize its RayDyLyo® range collaborating with Dara Pharmaceutical Packaging

The first automated vial-filling line adapted to the new closure device is being previewed at the CPhI in Frankfurt

ARaymondlife is a pharmaceutical company GMP EU, specialized in plastic injection molding and fastening solutions. Its technological expertise is applied to develop innovative solutions for the pharmaceutical laboratories (for human health and veterinary medicine) and the medical industry. More>>

Pertinax Pharma launches patented chlorhexidine technology, Pertinax®

Novel materials enable controlled and sustained release of chlorhexidine across a multitude of applications

Pertinax Pharma today announces the commercial launch of its unique, proprietary Pertinax® technology, which provides controlled and sustained delivery of chlorhexidine (CHX). More>>

Plasticell and GSK sign collaboration agreement to produce hematopoietic cells from iPSCs

It will screen combinations of molecules and enforce protocols

Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) to specific blood cell lineages for use by GSK in its therapeutic research More>>

STA Pharmaceutical to open new transition metal catalysis center in Changzhou, China

Center will introduce transition metal catalyst-screening technology

STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China. More>>

SCORR Marketing and Applied Clinical Trials Release Report on Collaborative R&D in the Drug Development Industry

Study on collaboration in the life sciences industry

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report. The report details the extent to which collaboration in the life sciences industry occurs and provides insight into the factors that influence this collaboration More>>

Delivering peace of mind

A novel approach to drug delivery from CDP is set to transform the patient experience

Help is on the horizon for patients juggling complicated treatment regimens for chronic diseases such as rheumatoid arthritis (RA). A novel approach to drug delivery from technology and product design firm Cambridge Design Partnership (CDP) paving the way for a new generation of treatment that is easier for patients and cost effective for healthcare providers. More>>

XenoGesis and Juniper Pharma Services strengthen alliance in early drug development services

They have done so through the addition of the gold standard PBPK modelling and simulation software, GastroPlus

XenoGesis and Juniper Pharma Services have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM More>>

New European Council of regulatory professionals set to shape and support the profession

RAPS to launch new European Council

The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and supporting its European expansion with the launch of its first ever RAPS European Council (REC) More>>

PCI Pharma Services Announces Acquisition of Millmount Healthcare

PCI targets European growth with acquisition of Dublin-based Millmount Healthcare

Philadelphia, PA – October 2, 2017 – Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) has announced the acquisition of pharmaceutical and healthcare contract packaging services provider Millmount Healthcare, located near Dublin, Ireland. More>>

CPhI Worldwide report highlights unpredictability in CDMO growth over next 5-years

Flow chemistry, fermentation, repatriation of overseas funds, oncology and API/product integration to grow, but the rate of change remains unclear

More>>